SCHEMBL313390

SCHEMBL313390

O=S(=O)(Cl)c1ccccc1-c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
HSD17B10 Q99714 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
PTGS2 P35354 2/20 0.45
AKR1B1 P15121 1/20 0.45
CYP2A6 P11509 1/20 0.44
CASP1 P29466 2/20 0.44
EDNRB P24530 4/20 0.42
EDNRA P25101 4/20 0.42
HPGD P15428 1/20 0.39
BCL2L1 Q07817 1/20 0.39
MAPK1 P28482 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
FBP1 P09467 1/20 0.38
NR1H2 P55055 1/20 0.38
BCAT2 O15382 1/20 0.38
PTGS1 P23219 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15879481 0.93 PTGS2 (0.48) ALDH1A1HSD17B10TDP1PTGS2AKR1B1
SCHEMBL31194215 0.90 PTGS2 (0.46) ALDH1A1HSD17B10TDP1PTGS2AKR1B1
SCHEMBL8196670 0.89 ALDH1A1 (0.61) ALDH1A1HSD17B10TDP1PTGS2AKR1B1
SCHEMBL17628496 0.88 ALDH1A1 (0.40) ALDH1A1HSD17B10TDP1PTGS2AKR1B1
SCHEMBL7127239 0.85 ALDH1A1 (0.48) ALDH1A1HSD17B10TDP1PTGS2MAPK1
SCHEMBL4202592 0.85 PTGS2 (0.55) ALDH1A1PTGS2HPGDFBP1PTGS1
SCHEMBL2008147 0.84 PTGS2 (0.53) ALDH1A1PTGS2PTGS1
SCHEMBL2007711 0.84 PTPRC (0.44) ALDH1A1HSD17B10TDP1PTGS2EDNRB
SCHEMBL7127244 0.84 ALDH1A1 (0.40) ALDH1A1HSD17B10TDP1PTGS2AKR1B1
SCHEMBL5682823 0.84 CA12 (0.42) ALDH1A1HSD17B10TDP1PTGS2EDNRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 298 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120020125-A Preparation method of biphenyl sulfide-containing compound 沈阳中化农药化工研发有限公司 2025-05-20 CN claimed
CN-108191746-B Hydroxypyridones compound and preparation method and application thereof 暨南大学 2020-06-16 CN claimed
US-12516028-B2 Triazinanes possessing thiosulfonate end-groups and methods of making them FLEXSYS IP HOLDINGS, LLC (US) 2026-01-06 US disclosed
EP-4229045-B1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER BROAD INST INC (US) 2025-11-12 EP disclosed
WO-2025224168-A1 ARYL SULFONE AND SULFANONE DERIVATIVES AS OREXIN RECEPTOR MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2025-10-30 WO disclosed
US-12378254-B2 Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2025-08-05 US disclosed
CN-120020125-A Preparation method of biphenyl sulfide-containing compound 沈阳中化农药化工研发有限公司 2025-05-20 CN disclosed
CN-119264303-A Pendant group functionalized fluorine-containing polymer, preparation method of fluorine-containing polymer, ion exchange membrane and application 佛山绿动氢能科技有限公司 2025-01-07 CN disclosed
WO-2024205303-A1 NOVEL AMIDE-BASED COMPOUND AND COMPOSITION COMPRISING SAME (주)아모레퍼시픽 2024-10-03 WO disclosed
US-20240287048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER BAYER AKTIENGESELLSCHAFT (DE) 2024-08-29 US disclosed
US-20240109901-A1 DISUBSTITUTED OCTAHYDROPYRROLO[3,4-C]PYRROLES AS OREXIN RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2024-04-04 US disclosed
US-4835312-A Production process of N-substituted amide compounds MITSUI CHEMICALS, INCORPORATED (JP) 1989-05-30 US disclosed
US-4710509-A IMIDAZOLE AND TRIAZOLE DERIVATIVES; FUNGICIDES NIHON TOKUSHU NOYAKU SEIZO K. K. (JP) 1987-12-01 US disclosed
EP-0173918-A2 Substituted phenylsulfonyl azoles NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1986-03-12 EP disclosed
EP-0138139-A2 Process for the preparation of substituted benzenesulfonyl chloride NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1985-04-24 EP disclosed
EP-0027906-B1 PROCESS FOR PREPARING SULPHON AMIDES BAYER AG (DE) 1983-05-25 EP disclosed
EP-0027906-A1 Process for preparing sulphon amides BAYER AG (DE) 1981-05-06 EP disclosed
US-4060549-A Process for preparing sulfonic acid fluorides BAYER AKTIENGESELLSCHAFT (DT) 1977-11-29 US disclosed
US-4007058-A Matrix construction for fuel cells MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1977-02-08 US disclosed
US-3966703-A Asymmetrical frisazo dyestuffs derived from diazotized 2,7-diamino-carbazole BAYER AKTIENGESELLSCHAFT (DT) 1976-06-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240287048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER KAT6A, KAT6B, KAT2A ALDH1A1 1125/4885HSD17B10 566/4885TDP1 2741/4885
US-20240109901-A1 DISUBSTITUTED OCTAHYDROPYRROLO[3,4-C]PYRROLES AS OREXIN RECEPTOR MODULATORS HCRTR2, HCRTR1, OXTR ALDH1A1 3132/4885HSD17B10 3775/4885TDP1 3692/4885
US-12378254-B2 Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators HCRTR2, HCRTR1, OXTR ALDH1A1 3132/4885HSD17B10 3775/4885TDP1 3692/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.